Related only in the sense that it is one of the potential indications.

Not sure which, if any, of these might combine well with RVX.

http://stm.sciencemag.org/content/7/278/278ra33

Per correspondence with QBI:

Working on mice, transitioning into working with sheep.

Will study safety and efficacy in sheep.

Few years before clinical trials in humans (hopefully).

Some dementias are caused by/in conjunction with tau proteins.

QBI is also working on this avenue, as are others.

Metabolic profiling distinguishes three types of Alzheimer's Disease (UCLA study):

http://www.impactaging.com/papers/v7/n8/pdf/100801.pdf

Ironic (and a piece on RVX would be a great follow-on to this):

http://www.cnn.com/2015/09/11/health/resveratrol-hope-for-alzheimers-patients/

http://neurosciencenews.com/neurology-alzheimers-three-subtypes-2655/

APOE2 potentially protective:

http://womensbrainhealth.org/think-outside-the-box/apoe2-may-be-a-protective-shield-against-alzheimers

Tau protein and cholesterol:

http://www.medicalnewstoday.com/releases/299537.php

Vitamin D:

http://www.medpagetoday.com/Neurology/Dementia/53560